Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call
MALVERN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing,...
Neuroscience
Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation for US Commercial Launch, if Approved
Minerva secures $80 million up front and up to an additional $80 million subject to the full exercise of...
Hengrui Pharma and Kailera Therapeutics Announce Phase 3 HRS9531 Obesity Data Presentation at ObesityWeek® 2025
Results from Hengrui’s completed Phase 3 clinical trial of HRS9531, a novel dual GLP-1/GIP receptor agonist with potentially best-in-category weight...
10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences
Collaboration enables researchers to begin exploring 10x single cell tools and datasets conversationally, with spatial applications to follow - making...
ADARx Pharmaceuticals Announces Clinical Data Presentation at the American Society of Nephrology (ASN) Kidney Week 2025
SAN DIEGO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA...
Peer-Reviewed Journal of Clinical Psychiatry Publishes Mentavi’s Online ADHD Diagnostic Evaluation Validation Study
Open-access publication demonstrates the validity and reliability of the Mentavi online Diagnostic Evaluation compared to a clinical interview, widening evidence...
Calico Appoints Philip R. Kym, Ph.D., as Head of Drug Discovery
SOUTH SAN FRANCISCO, Calif., Oct. 16, 2025 /PRNewswire/ -- Calico Life Sciences LLC (Calico), a biotechnology organization focused on aging...
MIRA Pharmaceuticals Announces Oral Mira-55 Outperformed Injected Morphine in Normalizing Pain and Reducing Inflammation, Supporting Its Planned IND for Chronic Inflammatory Pain
Findings show oral Mira-55 fully normalized pain and significantly reduced inflammation, supporting IND plans and reinforcing MIRA's position in a...
Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer
Mr. Kelly is a proven strategic CFO with significant financial, operational and commercialization leadership experienceVANCOUVER, British Columbia and BOSTON, Oct....
Nikon Small World Honors 51st Annual Photomicrography Competition
Winning image of a common agricultural pest reveals the beauty and complexity of insects often overlooked in daily life MELVILLE,...
MeSpace Names Neurable as Official Research Partner to Explore How Workspace Design Impacts Cognitive Performance
Initial pilot study reveals measurable gains in cognitive performance within MeSpace DALLAS, Oct. 15, 2025 /PRNewswire/ -- MeSpace, a Hollman...
Precision Neuroscience Named to Fast Company’s Next Big Things in Tech List
Award recognizes technology breakthroughs that promise to help define the future of their industriesNEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE)...
Lindamood-Bell’s Neuroscience-Based Instruction Helps Students Achieve Gains as National Scores Drop
SAN LUIS OBISPO, Calif., Oct. 13, 2025 /PRNewswire/ -- The latest National Assessment of Educational Progress (NAEP) report, often referred to...
BioXcel Therapeutics to Ring Nasdaq Closing Bell on October 14 to Celebrate a Transformative Milestone in Neuroscience Innovation
NEW HAVEN, Conn., Oct. 13, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company pioneering the use...
Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference
Panel discussion featured at the International Society of Pain and Neuroscience (ISPN) Annual Meeting in London titled United to Conquer...
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States
EINDHOVEN, the Netherlands, Oct. 13, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading...
NeuroVigil’s iBrain™ in TIME’s “Best Inventions of 2025”
iBrain™ - Copyright © 2025 NeuroVigil, Inc. All Rights Reserved. iBrain™ prototype iBrain™ with two quarters - Copyright © 2025...
Executive Wellness Retreats: Grey Matters International Announces Expansion of Neuroscience-Based Programs
Discover a neuroscience-based path to better mental health and executive well-being with Grey Matters International. Their personalized retreats combine brain...
Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer’s Disease Research
New Blood-Based Assay Delivers Unparalleled Sensitivity and Specificity to enable the next generation of assay development. FREMONT, Calif., Oct. 9,...
10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025
PLEASANTON, Calif., Oct. 9, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it...